David Roman
Stock Analyst at Goldman Sachs
(0.61)
# 2281
Out of 5,328 analysts
38
Total ratings
26.32%
Success rate
1.41%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
TDOC Teladoc Health | Maintains: Buy | 13 10 | 7.02 | 42.45% | 4 | May 1, 2025 | |
GEHC GE HealthCare Techs | Maintains: Buy | 94 82 | 68.01 | 20.57% | 3 | May 1, 2025 | |
KMTS Kestra Medical Techs | Maintains: Neutral | 24 23 | 22.89 | 0.48% | 2 | Apr 16, 2025 | |
HQY HealthEquity | Maintains: Neutral | 107 94 | 87.93 | 6.9% | 2 | Mar 27, 2025 | |
ABT Abbott Laboratories | Maintains: Strong Buy | 138 154 | 131.07 | 17.49% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 42 24 | 20.28 | 18.34% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 63 71 | 65.95 | 7.66% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 64 55 | 36.92 | 48.97% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 42 | 30.77 | 36.5% | 3 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 91 124 | 110.06 | 12.67% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 58 80 | 58.62 | 36.47% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 384 427 | 374.75 | 13.94% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 81 90 | 75.72 | 18.86% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 90 | 103.66 | -13.18% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 500 | 519.8 | -3.81% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 274 | 172.22 | 59.1% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 129 | 102.14 | 26.3% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 83 | 83.65 | -0.78% | 1 | May 30, 2024 |